Fundraising Fox

Labviva

6 known investors

labviva.com ↗

Labviva is an AI-native procurement platform that unifies the life sciences supply chain, helping research organizations optimize procurement processes and reduce costs. The platform serves life sciences companies and research institutions by automating lab operations and inventory management.

AI & Machine LearningBiotechEnterprise SoftwareSaaSin /labviva

Founders & leadership

S
Siamakin
R
Renikain
J
Jenniferin
C
CarloinGM of Europe
NP
Nick PremnathinSVP of Commercial Strategy
SF
Sarah FayDirector
AM
Aaron MiramontesExecutive Officer
NR
Nicholas RiouxExecutive Officer, Director
SB
Siamak BaharlooExecutive Officer, Director

Investors · 6

BIOSPRING PARTNERS✓ verifiedNew York
Glasswing Ventures✓ verifiedBoston · $100K – $5M
Village Global✓ verifiedCovina · $100K – $500K
B Capital GroupManhattan Beach · $10M – $50M
B4 Capital$10M – $50M
MassVenturesWaltham · $250K – $500K

Reported raises · per SEC filings

Form D private placements
▶$8MraisedJun 2021 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas RiouxExecutive Officer, Director
  • Evan LodesDirector
  • Siamak BaharlooExecutive Officer, Director
  • Aaron MiramontesExecutive Officer
  • Sarah FayDirector
Offering amount
$8M
Amount sold
$8M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedMay 2019 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sarah FayDirector
  • Aaron MiramontesExecutive Officer
  • Nicholas RiouxExecutive Officer, Director
  • Siamak BaharlooExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$750K
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news